Gene therapy for macular degeneration: Uses and more
Medical News Today· 3 days agoSeveral gene therapies are undergoing clinical trials. In this article, learn more about gene therapy and its potential role in treating macular ...
Measuring levels of proteins in eye fluid may accurately predict need for lifelong macular ...
Medical Xpress· 4 days agoIn a study of eye fluid from 38 patients, Johns Hopkins Medicine researchers say they have found...
Macular degeneration and diabetes: Links and more
Medical News Today· 3 days agoMacular degeneration describes a loss of central vision due to damage to part of the retina. People with diabetes might have an increased risk of...
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted
MSN News· 5 hours agoRegeneron Pharmaceuticals, Inc. REGN recently announced that its supplemental biologics License Application (sBLA) for ophthalmology drug Eylea has been accepted by the FDA for review. Eylea ...
EYLEA® (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic...
FOX 59 Indianapolis· 4 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the EYLEA® (aflibercept) Injection supplemental Biologics License ...
2-Year Faricimab Results: 'Visual Gains With Fewer Injections'
Medscape· 6 days agoThe trials compared two dosing regimens of faricimab — including a personalized treatment interval...
NHS delays: Avoidable blindness fears over eye care waits
BBC News· 5 days agoA "tide of avoidable blindness" could sweep Wales if eye care services are not reformed, a...
OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of...
Morningstar· 2 days agoThe objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
NVISION® Eye Centers Continues National Expansion
WTNH-TV New Haven· 3 days agoALISO VIEJO, Calif. , June 30, 2022 /PRNewswire/ -- NVISION® Eye Centers is pleased to announce the addition of two retina practices to the NVISION family – Salt Lake Retina in Salt Lake City ...
Ocugen, Inc. (NASDAQ:OCGN) Position Increased by Dynamic Advisor Solutions LLC
ETF DAILY NEWS· 5 days agoDynamic Advisor Solutions LLC raised its holdings in shares of Ocugen, Inc. (NASDAQ:OCGN – Get Rating) by 122.6% in the 1st quarter, according to the company in its most recent disclosure with ...
